[go: up one dir, main page]

NO923974L - Triazaspirodecanon-metylchroman - Google Patents

Triazaspirodecanon-metylchroman

Info

Publication number
NO923974L
NO923974L NO92923974A NO923974A NO923974L NO 923974 L NO923974 L NO 923974L NO 92923974 A NO92923974 A NO 92923974A NO 923974 A NO923974 A NO 923974A NO 923974 L NO923974 L NO 923974L
Authority
NO
Norway
Prior art keywords
medicaments
triazaspirodecanon
metylchroman
triazaspirodecanones
triazaspirodecanonemethylchromans
Prior art date
Application number
NO92923974A
Other languages
English (en)
Norwegian (no)
Other versions
NO923974D0 (no
Inventor
Hans-Georg Heine
Rudolf Schohe-Loop
Thomas Glaser
Jean Marie Viktor De Vry
Wolfgang Dompert
Henning Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO923974D0 publication Critical patent/NO923974D0/no
Publication of NO923974L publication Critical patent/NO923974L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO92923974A 1991-10-28 1992-10-13 Triazaspirodecanon-metylchroman NO923974L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135473A DE4135473A1 (de) 1991-10-28 1991-10-28 Triazaspirodecanon-methylchromane

Publications (2)

Publication Number Publication Date
NO923974D0 NO923974D0 (no) 1992-10-13
NO923974L true NO923974L (no) 1993-04-29

Family

ID=6443565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923974A NO923974L (no) 1991-10-28 1992-10-13 Triazaspirodecanon-metylchroman

Country Status (19)

Country Link
US (1) US6060482A (zh)
EP (1) EP0539803B1 (zh)
JP (1) JP3257708B2 (zh)
KR (1) KR930007945A (zh)
AT (1) ATE175414T1 (zh)
AU (1) AU650792B2 (zh)
CA (1) CA2081256A1 (zh)
CZ (1) CZ322492A3 (zh)
DE (2) DE4135473A1 (zh)
DK (1) DK0539803T3 (zh)
ES (1) ES2125879T3 (zh)
FI (1) FI924848A (zh)
GR (1) GR3029450T3 (zh)
HU (1) HUT64068A (zh)
IL (1) IL103546A0 (zh)
MX (1) MX9205869A (zh)
NO (1) NO923974L (zh)
TW (1) TW208010B (zh)
ZA (1) ZA928290B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
JP3989247B2 (ja) * 1999-12-06 2007-10-10 ユーロ−セルティーク エス.エイ. ノシセプチン受容体親和性を有するトリアゾスピロ化合物
US20050014818A1 (en) * 2001-11-09 2005-01-20 Masaru Mitsuda Process for producing optically active chroman derivative and intermediate
US6995168B2 (en) * 2002-05-31 2006-02-07 Euro-Celtique S.A. Triazaspiro compounds useful for treating or preventing pain
JP4712384B2 (ja) * 2002-09-09 2011-06-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Orl−1受容体介在障害の治療に有用なヒドロキシアルキル置換1,3,8−トリアザスピロ[4.5]デカン−4−オン誘導体
WO2005036104A1 (en) * 2003-10-16 2005-04-21 Collier William R Fluid level detector and alarm apparatus
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
EP2102206B1 (en) * 2006-11-28 2015-04-08 Janssen Pharmaceutica NV Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
CN101679430B (zh) * 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4826848A (en) * 1985-04-15 1989-05-02 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination

Also Published As

Publication number Publication date
ATE175414T1 (de) 1999-01-15
HU9203382D0 (en) 1993-01-28
EP0539803A1 (de) 1993-05-05
DE4135473A1 (de) 1993-04-29
KR930007945A (ko) 1993-05-20
TW208010B (zh) 1993-06-21
JPH05222040A (ja) 1993-08-31
IL103546A0 (en) 1993-03-15
GR3029450T3 (en) 1999-05-28
ES2125879T3 (es) 1999-03-16
AU2626592A (en) 1993-04-29
CZ322492A3 (en) 1993-07-14
AU650792B2 (en) 1994-06-30
JP3257708B2 (ja) 2002-02-18
DE59209607D1 (de) 1999-02-18
CA2081256A1 (en) 1993-04-29
ZA928290B (en) 1993-05-04
US6060482A (en) 2000-05-09
HUT64068A (en) 1993-11-29
MX9205869A (es) 1993-04-01
NO923974D0 (no) 1992-10-13
EP0539803B1 (de) 1999-01-07
FI924848A0 (fi) 1992-10-26
FI924848A (fi) 1993-04-29
DK0539803T3 (da) 1999-08-30

Similar Documents

Publication Publication Date Title
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
TW289020B (zh)
FI921087A0 (fi) Nya estrar av tienylkarboxylsyror och aminoalkoholer, deras kvaterniseringsprodukter och framstaellning och anvaendning av naemnda foereningar.
NL300181I1 (nl) N-(pyrroloÄ2,3-dÜpyrimidine-3-ylacyl)-glutaminezuurderivaten.
FI924848A (fi) Triazaspirodekanon-metylkromaner
DE3870959D1 (de) 2-difluormethoxy-1,1,1,2-tetrafluoraethan als anaesthetikum.
AU7736191A (en) Oxazolidinones
NO941958D0 (no) Fremstilling av substituerte piperidiner
NO930029L (no) 4,13-dioxabicyklo(8.2.1)tridecenonderivater, fremgangsmaater og mellomprodukter for deres fremstilling, og legemidler inneholdene disse forbindelser
ATE72434T1 (de) Pyrazolsulfonamide-derivate, verfahren zu deren herstellung und diese enthaltende herbizide mittel.
ITRM920153U1 (it) Crociera centrale per treppiede.
NO881997D0 (no) Nye 4-benzyl-1-(2h)-ftalazinonderivater med en aminosyrerest.
DE3881866D1 (de) System zur belichtungsadressierung hoher aufloesung mit grobaufgeloestem belichtungsfeld.
AU588065B2 (en) Substituted diazaoxaspirodecanes, preparation thereof and use thereof as stabilizers for polymers
EP0627436A4 (en) CARCINOSTATIC CONNECTIONS AND THEIR PRODUCTION.
FI864970L (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
DE68906049D1 (de) Benzocyclohexan- und benzocycloheptan-derivate und deren salze, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als heilmittel und diese enthaltende zusammensetzungen.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
MX9202930A (es) Procedimiento microbiologico para preparar acido 5-hidroxi-pirazincarboxilico.
ATE157081T1 (de) Beta-phenylisoserin-(2r,3s), ihre salze, herstellung und verwendung
PT746556E (pt) Compostos triciclicos com afinidade para o receptor 5-ht1a
DK0547502T3 (da) Hærdeligt bindemiddel og fremgangsmåde til fremstilling deraf
DK0478941T3 (da) Lægemidler indeholdende substituerede 2-cyclohexen-1-yl-amin-derivater og deres anvendelse til bekæmpelse af sygdomme
FI855149A0 (fi) Nya n-(2-hydroxialkyl)aminosyror och deras derivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI883505L (fi) (1r,5s,6s)-2-substituerad-tio -6-/(r)-1-hydroxietyl/-1-metylkarbapenem-3 -karboxylsyraderivat.